Aquestive Therapeutics (AQST) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Aquestive Therapeutics (AQST) over the last 6 years, with Q3 2025 value amounting to -$0.14.
- Aquestive Therapeutics' EPS (Weighted Average and Diluted) fell 769.23% to -$0.14 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.71, marking a year-over-year decrease of 5434.78%. This contributed to the annual value of -$0.51 for FY2024, which is 29147.96% down from last year.
- Per Aquestive Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.14 for Q3 2025, which was down 769.23% from -$0.14 recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' EPS (Weighted Average and Diluted) ranged from a high of $0.11 in Q1 2023 and a low of -$0.76 during Q4 2021
- Over the past 5 years, Aquestive Therapeutics' median EPS (Weighted Average and Diluted) value was -$0.2 (recorded in 2024), while the average stood at -$0.22.
- In the last 5 years, Aquestive Therapeutics' EPS (Weighted Average and Diluted) crashed by 37664.91% in 2021 and then skyrocketed by 13437.5% in 2023.
- Quarter analysis of 5 years shows Aquestive Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.76 in 2021, then soared by 66.66% to -$0.25 in 2022, then skyrocketed by 48.71% to -$0.13 in 2023, then plummeted by 51.27% to -$0.2 in 2024, then rose by 28.81% to -$0.14 in 2025.
- Its last three reported values are -$0.14 in Q3 2025, -$0.14 for Q2 2025, and -$0.24 during Q1 2025.